Hepatic Veno-Occlusive Disease following Stem Cell Transplantation: Incidence, Clinical Course, and OutcomeJason Coppell, Dietger Niederwieser, Paul G. Richardson et al.|Biology of Blood and Marrow Transplantation|2009Cited by 595
Ipilimumab for Patients with Relapse after Allogeneic TransplantationMatthew S. Davids, Robert J. Soiffer, Haesook T. Kim et al.|New England Journal of Medicine|2016Cited by 595
Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for LymphomaChristopher J. Gibson, Benjamin L. Ebert, R. Coleman Lindsley et al.|Journal of Clinical Oncology|2017Cited by 468
Blood and Marrow Transplant Clinical Trials Network Toxicity Committee Consensus Summary: Thrombotic Microangiopathy after Hematopoietic Stem Cell TransplantationVincent T. Ho, Sergio Giralt, Corey Cutler et al.|Biology of Blood and Marrow Transplantation|2005Cited by 458
Optimizing Autologous Stem Cell Mobilization Strategies to Improve Patient Outcomes: Consensus Guidelines and RecommendationsSergio Giralt, Steven M. Devine, Luciano J. Costa et al.|Biology of Blood and Marrow Transplantation|2013Cited by 402